Tessa Therapeutics to build commercial-scale facility for VST therapies

19th December 2019 Uncategorised 0

A Singapore biotech that has been manufacturing virus-specific T cells for its clinical studies is ready to scale up. Tessa Therapeutics will build a 90,000 square foot global cell therapy manufacturing facility in Singapore. 

More: Tessa Therapeutics to build commercial-scale facility for VST therapies
Source: fierce